ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Medicamen Biotech Ltd reported revenue from operations of ₹4,790 Cr (+11.3% YoY) and net profit of ₹184.6 Cr (+15.3% YoY) for Q1 FY27.
Medicamen Biotech Ltd reported revenue from operations of ₹47.9 Cr (+11.4% YoY) and net profit of ₹1.8 Cr (+12.5% YoY) for Q1 FY27.
Medicamen Biotech Ltd reported revenue from operations of ₹60.6 Cr (+104.7% YoY) and net profit of ₹4.4 Cr (+131.6% YoY) for Q4 FY26.
Medicamen Biotech approved audited FY26 financial results and recommended a Rs. 1.00 per share final dividend. The board also appointed new cost and internal auditors.